(Q114738429)
Statements
Biochemical and immunologic correlates of clinical response in a combination trial of the GM-CSF-gene transduced allogeneic prostate cancer immunotherapy and ipilimumab in patients with metastatic hormone-refractory prostate cancer (mHRPC) (English)
W. R. Gerritsen
A. J. van den Eertwegh
T. D. de Gruijl
G. Giaccone
R. J. Scheper
N. Sacks
T. Harding
I. Lowy
E. Stankevich
K. Hege
6 March 2020
18_suppl
5120-5120